RUNX1 and lung cancer: To determine if RUNX1 hypermethylation may be a biomarker for the detection of NSCLC in other races, we tested RUNX1 hypermethylation in the 899 TCGA primary lung cancers (75 normal tissues and 824 tumor tissues).